JPC
ABBV icon

Jackson Park Capital’s AbbVie ABBV Stock Holding History

Jackson Park Capital’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-10,000
Closed -$586K – 33
2015
Q1 		$586K Sell
10,000
-24,000
-71% -$1.45M 0.5% 31
2014
Q4 		$2.23M Buy
+34,000
New +$2.14M 1.77% 26

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Jackson Park Capital's ABBV Position: Q2 2015 in Review

Jackson Park Capital sold out of AbbVie (ABBV) in Q2 2015, closing a stake of 10,000 shares — an estimated $586K sold.

Jackson Park Capital first reported a position in ABBV in Q4 2014 and held it in 2 quarters. The position peaked at $2.23M in Q4 2014. 1,654 funds tracked by Wall St. Rank hold ABBV as of Q2 2015.

  • Jackson Park Capital reported no remaining AbbVie position as of Q2 2015 after selling out during the quarter.
  • Jackson Park Capital sold 10,000 AbbVie shares in Q2 2015, an estimated $586K.
  • Jackson Park Capital first reported a position in AbbVie in Q4 2014 and held it in 2 quarters.
  • Jackson Park Capital's AbbVie position peaked at $2.23M in Q4 2014.
  • 1,654 funds tracked by Wall St. Rank held AbbVie as of Q2 2015.

Based on Jackson Park Capital's 13F filing for Q2 2015, filed 29 Jul 2015.